Xbrane Biopharma AB (XBRANE) — Capital Reinvestment Ratio
Xbrane Biopharma AB (XBRANE) has a Capital Reinvestment Ratio of 0.18x as of December 2024, meaning it reinvests 0% of its operating cash flow (Skr93.91 Million) in capital expenditures (Skr17.30 Million). See debt-free asset ratio of Xbrane Biopharma AB to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xbrane Biopharma AB Capital Reinvestment Ratio (2018–2018)
This chart tracks Xbrane Biopharma AB's Capital Reinvestment Ratio across 1 annual periods. Check XBRANE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xbrane Biopharma AB (2018–2018)
Year-by-year Capital Reinvestment Ratio for Xbrane Biopharma AB from 2018 to 2018. For live market cap and broader valuation context, see how much is Xbrane Biopharma AB worth.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.03x | Skr46.71 Million | Skr1.60 Million | — |